GAITHERSBURG, Md., Nov. 8, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that the Company's management will participate in a panel discussion entitled, "The 2010 Gems in Wound Care Panel," hosted by Rodman and Renshaw, LLC on Thursday, November 11, 2010 at 4:30 p.m. Eastern time in Rodman and Renshaw's offices. The event will be moderated by Michael Higgins, Senior Specialty Pharmaceuticals Analyst, and Suraj Kalia, Senior Medical Devices Analyst at Rodman and Renshaw.
